DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. BCRP Research Highlights/News
  3. 2009 Breast Cancer Research Program

NEWS RELEASE

Released: December 15, 2008

Department of Defense Breast Cancer Research Program
Funding Opportunities for Fiscal Year 2009

The Fiscal Year 2009 (FY09) Defense Appropriations Act provides $150 million to the Department of Defense Breast Cancer Research Program (BCRP) to support innovative, high-impact breast cancer research. This program is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of Congressionally Directed Medical Research Programs (CDMRP).

FY09 BCRP program announcements and application instructions for the following award mechanisms are anticipated to be posted on Grants.gov in January 2009.

Award Mechanism Eligibility Key Mechanism Elements Funding
Predoctoral Traineeship Award Principal Investigator: Graduate student enrolled in a PhD or MD/PhD program

Mentor: Must have breast cancer experience, to include current funding and publications
  • Supports the training of promising graduate students studying breast cancer research under the guidance of a designated mentor
  • The predoctoral trainee is considered the PI and should write the proposal with appropriate direction from the mentor
  • Training program should prepare the trainee for an independent career in breast cancer research
  • Maximum funding of $120K for direct costs (plus indirect costs)
  • Period of performance not to exceed 3 years
Postdoctoral Fellowship Award Principal Investigator: Doctoral graduates (PhD or MD)

No more than 2 years in the proposed research setting and no more than 4 years' postdoctoral research experience

Mentor or formal co-mentor: Must have breast cancer experience, to include current funding and publications
  • Supports exceptionally talented recent doctoral graduates who have the ambition and ability to pursue an independent career at the forefront of breast cancer research
  • Proposed research should be innovative and have the potential for high impact
  • Proposed training and mentorship should facilitate development of the PI as a breast cancer researcher
  • Maximum funding of $300K for direct costs (plus indirect costs)
  • Period of performance not to exceed 3 years.
HBCU/MI Partnership Training Award Principal Investigator/Co-investigator(s): HBCU/MI faculty member with doctoral degree

Mentor(s): Must have an established breast cancer research program at the mentoring institution
  • Supports two or more faculty-level investigators at an HBCU/MI to acquire mentored training in breast cancer research
  • Supports the establishment of a sustainable breast cancer research program at the applicant HBCU/MI
  • Proposed research and training should lead to publication(s) and independent breast cancer research funding
  • Maximum funding of $1M for direct costs (plus indirect costs).
  • Period of performance not to exceed 4 years.
Era of Hope Scholar Award Independent, non-mentored investigators within 6 years of their last mentored position as of the nomination deadline
  • Supports exceptionally talented, creative early-career scientists who have demonstrated that they are the "best and brightest" in their fields
  • Individuals should exhibit strong potential for leadership in the breast cancer community
  • Nomination letter is required; proposal submission is by invitation only
  • Maximum funding of $2.5M for direct costs (plus indirect costs).
  • Period of performance not to exceed 5 years.
Innovator Award Investigators at all academic levels (or equivalent)
  • Supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field
  • Provides opportunity to pursue novel, visionary, high-risk ideas that could ultimately lead to the eradication of breast cancer
  • Nomination letter is required; proposal submission is by invitation only
  • Maximum funding of $5M for direct costs (plus indirect costs).
  • Period of performance not to exceed 5 years.
Idea Award Investigators at all academic levels (or equivalent)

Investigators at all academic levels (or equivalent)
  • Supports conceptually innovative, high-risk/high-reward research from all areas of basic, translational, clinical, behavioral, and epidemiological research
  • Innovation is the most important review criterion
  • Preliminary data discouraged, strength of proposal should not rely on preliminary data
  • New! Collaborative Option supports combining expertise of two principal investigators to more effectively address an innovative research question
  • Maximum funding of $375K for direct costs (plus indirect costs). Period of performance not to exceed 2 years.
  • For Collaborative Option: Maximum funding of $550K for direct costs (plus indirect costs). Period of performance not to exceed 2 years.
  • For Population-Based Studies: Maximum funding of $650K for direct costs (plus indirect costs). Period of performance not to exceed 5 years.
Impact Award Investigators at all academic levels (or equivalent)
  • Supports unique projects that possess strong potential to have a significant impact in breast cancer
  • Impact is the most important review criterion (innovation is not a criterion)
  • Impact can include advances in basic or clinical research and may be short- or long-term
  • Focus on important but understudied issues in breast cancer research such as prevention and risk factors is strongly encouraged
  • Preproposal is required; proposal submission is by invitation only
  • Maximum funding of $2M for direct costs (plus indirect costs).
  • Period of performance not to exceed 5 years.
Integrated Multi-Team Research Award Three independent, faculty-level (or equivalent) investigators

Must include a basic investigator, a clinical investigator, and an investigator from any other area of expertise
  • Supports three innovative investigators and their research teams in a coordinated and integrated translational research effort to address a question of major importance in breast cancer
  • Teams must include consumer advocates
  • Multiple institutions must be involved
  • A clear plan for intensive collaboration among the teams must be demonstrated
  • Regular in-person meetings and on-site cross-training of investigators among the research teams will be required
  • Preproposal is required; proposal submission is by invitation only
  • Maximum funding of $4.5M for direct costs (plus indirect costs).
  • Period of performance not to exceed 4 years.

Information in this pre-announcement is being provided to allow investigators time to plan and develop proposals. All proposals must conform to the final program announcements and application instructions that will be available for electronic downloading from the Grants.gov website in January 2009. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to proposal submission. Proposals must be submitted through the federal government's single-entry portal, Grants.gov. Requests for email notification of the program announcements release may be sent to help@cdmrp.org. For more information about the BCRP or other CDMRP-administered programs, please visit the CDMRP website (https://CDMRP.HEALTH.MIL).

Point of Contact:


Last updated Tuesday, November 12, 2024